172 related articles for article (PubMed ID: 21846691)
1. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
Alymova IV; Portner A; Mishin VP; McCullers JA; Freiden P; Taylor GL
Glycobiology; 2012 Feb; 22(2):174-80. PubMed ID: 21846691
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
[TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.
Fukushima K; Takahashi T; Ueyama H; Takaguchi M; Ito S; Oishi K; Minami A; Ishitsubo E; Tokiwa H; Takimoto T; Suzuki T
FEBS Lett; 2015 May; 589(11):1278-82. PubMed ID: 25871520
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus.
Ryan C; Zaitsev V; Tindal DJ; Dyason JC; Thomson RJ; Alymova I; Portner A; von Itzstein M; Taylor G
Glycoconj J; 2006 Feb; 23(1-2):135-41. PubMed ID: 16575531
[TBL] [Abstract][Full Text] [Related]
5. Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors.
Eveno T; Dirr L; El-Deeb IM; Guillon P; von Itzstein M
Viruses; 2019 May; 11(5):. PubMed ID: 31060278
[TBL] [Abstract][Full Text] [Related]
6. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
Alymova IV; Taylor G; Mishin VP; Watanabe M; Murti KG; Boyd K; Chand P; Babu YS; Portner A
J Virol; 2008 Sep; 82(17):8400-10. PubMed ID: 18579600
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.
Murrell MT; Porotto M; Greengard O; Poltoratskaia N; Moscona A
J Virol; 2001 Jul; 75(14):6310-20. PubMed ID: 11413297
[TBL] [Abstract][Full Text] [Related]
8. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin.
Amonsen M; Smith DF; Cummings RD; Air GM
J Virol; 2007 Aug; 81(15):8341-5. PubMed ID: 17522226
[TBL] [Abstract][Full Text] [Related]
9. Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase.
Tappert MM; Smith DF; Air GM
J Virol; 2011 Dec; 85(23):12146-59. PubMed ID: 21917945
[TBL] [Abstract][Full Text] [Related]
10. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.
Bousse T; Takimoto T
J Virol; 2006 Sep; 80(18):9009-16. PubMed ID: 16940513
[TBL] [Abstract][Full Text] [Related]
11. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus.
Kubota M; Matsuoka R; Suzuki T; Yonekura K; Yanagi Y; Hashiguchi T
J Virol; 2019 Aug; 93(15):. PubMed ID: 31118251
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
[TBL] [Abstract][Full Text] [Related]
15. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
Streltsov VA; Pilling P; Barrett S; McKimm-Breschkin JL
Antiviral Res; 2015 Nov; 123():216-23. PubMed ID: 26364554
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin-Neuraminidase Using Unsaturated 3- N-Substituted Sialic Acids as Probes.
Pascolutti M; Dirr L; Guillon P; Van Den Bergh A; Ve T; Thomson RJ; von Itzstein M
ACS Chem Biol; 2018 Jun; 13(6):1544-1550. PubMed ID: 29693380
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Human Parainfluenza Virus Receptor Using Terminal Sialic Acid Linkage-Modified Cells.
Fukushima K; Takahashi T; Suzuki T
Methods Mol Biol; 2022; 2556():169-178. PubMed ID: 36175634
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.
Crennell S; Takimoto T; Portner A; Taylor G
Nat Struct Biol; 2000 Nov; 7(11):1068-74. PubMed ID: 11062565
[TBL] [Abstract][Full Text] [Related]
19. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.
Porotto M; Fornabaio M; Kellogg GE; Moscona A
J Virol; 2007 Apr; 81(7):3216-28. PubMed ID: 17229690
[TBL] [Abstract][Full Text] [Related]
20. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
